CCL-2 is an HDAC-regulated chemokine, with a pivotal role in facilitating the generation of a tumor-permissive and immune-suppressive microenvironment, via the accruement of myeloid immunosuppressive cell populations. Here, CCL2 is linked to neoplasm.